Five entities – four companies and one executive – are now being probed by the Competition Commission of India after complaints of anticompetitive stockiest-ship appointments. Pharmaceutical companies Cipla, Macleods Pharmaceutical and FDC Ltd are all under investigation, as well as the trade body Himachal Pradesh Society of Chemist and Druggist Alliance, as well as its president. According to reports, the CCI is looking into allegations that the trade body illegally controlled the appointment of stockist-ship of the pharmaceutical companies that are part of the Society. The CCI has recognized the complaints that competitors could not be granted stockish-ship due to the collusive agreements.
Featured News
DOJ Clears Paramount’s $110 Billion Warner Bros. Discovery Acquisition
Jun 12, 2026 by
CPI
States Move Ahead with AI Safeguards for Minors as Federal Action Remains Uncertain
Jun 12, 2026 by
CPI
Dana, Eaton Strike Auto Parts Deal Worth More Than $10 Billion
Jun 11, 2026 by
CPI
CFTC Proposes New Rules For What’s Allowed on Prediction Markets
Jun 11, 2026 by
CPI
Connecticut vs. California’s Data Broker Laws: New Compliance Challenges
Jun 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani